Evaluation of commonly used analysis strategies for epigenome- and transcriptome-wide association studies through replication of large-scale population studies by van Rooij, J. (Jeroen) et al.
RESEARCH Open Access
Evaluation of commonly used analysis
strategies for epigenome- and
transcriptome-wide association studies
through replication of large-scale
population studies
Jeroen van Rooij1*† , Pooja R. Mandaviya1,2†, Annique Claringbould3, Janine F. Felix4,5, Jenny van Dongen6,
Rick Jansen7, Lude Franke8, BIOS consortium, Peter A. C. ’t Hoen9,10†, Bas Heijmans11† and Joyce B. J. van Meurs1*†
Abstract
Background: A large number of analysis strategies are available for DNA methylation (DNAm) array and RNA-seq
datasets, but it is unclear which strategies are best to use. We compare commonly used strategies and report how
they influence results in large cohort studies.
Results: We tested the associations of DNAm and RNA expression with age, BMI, and smoking in four different cohorts
(n = ~ 2900). By comparing strategies against the base model on the number and percentage of replicated CpGs for
DNAm analyses or genes for RNA-seq analyses in a leave-one-out cohort replication approach, we find the choice of the
normalization method and statistical test does not strongly influence the results for DNAm array data. However, adjusting
for cell counts or hidden confounders substantially decreases the number of replicated CpGs for age and increases the
number of replicated CpGs for BMI and smoking. For RNA-seq data, the choice of the normalization method, gene
expression inclusion threshold, and statistical test does not strongly influence the results. Including five principal
components or excluding correction of technical covariates or cell counts decreases the number of replicated genes.
Conclusions: Results were not influenced by the normalization method or statistical test. However, the correction
method for cell counts, technical covariates, principal components, and/or hidden confounders does influence the results.
Keywords: Illumina 450k arrays, DNA methylation, EWAS, RNA sequencing, Differential gene expression, TWAS, Statistical
methods comparison
Background
Epigenomics and transcriptomics are important tools
to investigate molecular mechanisms of disease eti-
ology. Unlike the genome, the epigenome and tran-
scriptome are dynamic and differ across tissues and
over time [1–4]. Consequently, an epigenome-wide or
transcriptome-wide association study (EWAS or
TWAS, respectively) is influenced by more biological
and technical factors than a genome-wide association
study (GWAS). As a result, EWAS and TWAS
methods are less standardized and do not always
present the same results. For example, EWASs com-
paring current smokers with never smokers resulted
in different significant CpGs and different numbers of
significant CpGs per study, independent of sample
size [5–15]. Similarly, TWASs comparing current
smokers with never smokers found different numbers
of associated genes [16–19]. Although these studies
took place in different populations, they also used
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different analytical strategies, which could explain part
of the variation in results.
For DNA methylation (DNAm) array data, previous
studies compared different normalization methods [20–
24]. Wu et al. concluded that most normalization
methods performed similarly in association analyses
when there was a strong association between CpGs and
the exposure of interest [20]. To investigate the perform-
ance of DNAm values, Du et al. compared the use of
beta values with M values in two samples and concluded
that M values had better statistical properties, whereas
beta values were more biologically interpretable [25].
Furthermore, white blood cell (WBC) counts are often
used as important confounder adjustments for EWASs
in whole blood. Cell counts estimated using the House-
man method [26] are commonly used when measured
cell counts are not available. However, since the House-
man method is based on only six reference individuals
[27], thorough investigation of this method based on
large-scale DNAm data is needed. Lastly, principal com-
ponents (PCs), surrogate variables (SVs), or unobserved
covariates (also known as hidden confounders (HCs))
are commonly used methods to adjust for unmeasured
hidden (technical or biological) confounders. Estimation
of HCs using CATE has been suggested to outperform
covariate adjustment using PCs or SVs [27, 28].
For RNA sequencing (RNA-seq) data, Li et al. com-
pared a range of normalization methods and concluded
that the commonly used options (e.g., DESeq/edgeR)
provided the highest accuracy at the cost of decreased
sensitivity compared to options with more specific appli-
cations [29]. When sufficient replicates (n > 4) per group
were used, all methods performed similarly. Li et al. also
compared normalization methods and concluded that
commonly used options performed similarly, although
some specific methods performed better for short (35
bp) read lengths and/or when alignment quality was low
[29]. Several studies focused on other aspects of the ana-
lysis procedure such as the gene database used for
quantifications (i.e., RefSeq, UCSC, and Ensembl) or se-
quencing platform and flowcell effect on results [30–32].
However, a comprehensive examination of multiple
steps and combinations of analysis options is still
lacking.
Most of these previous studies focused on a specific as-
pect of the procedure using simulated data or small data-
sets. To provide a complete evaluation of analysis
strategies, we analyzed, replicated, and compared analysis
strategies composed of commonly used normalization,
correction, and association options in four large
population-based datasets of the BIOS project, which have
both DNAm array and RNA-seq data available [33, 34].
Because of this design, we can replicate results across co-
horts and evaluate analysis strategies based on their repli-
cation performance. Our evaluation will help researchers
select the optimal strategy and reduce unnecessary vari-
ation across studies. In addition, information about strat-
egy differences will be helpful when comparing studies
where different analysis strategies are used.
Results
Table 1 shows phenotypic characteristics for the four co-
horts analyzed. To accommodate the differences in char-
acteristics of the cohorts, cohorts were meta-analyzed.
Figure 1 shows the various analysis strategies under
evaluation. We selected a base model for DNAm and
RNA-seq analysis comprised of one option in each cat-
egory. Then, per category, we swapped the option in the
base model with the alternatives and evaluate the repli-
cation performance against the base model. The categor-
ies for DNAm were (A) DNAm value preprocessing, (B)
statistical test, (C) cell counts, and (D) hidden con-
founders. The categories for RNA-seq were (A)
normalization method, (B) expression inclusion thresh-
old, (C) statistical test, and (D) technical covariates.
Each analysis strategy was meta-analyzed across three
cohorts and replicated in the fourth, in all four combina-
tions (the so-called leave-one-out method). Both meta-
Table 1 Characteristics of the four main cohorts at the time of blood draw. All entries represent averages with standard deviations
unless otherwise indicated
Phenotypes DNA methylation RNA-seq
LL LLS NTR RS LL LLS NTR RS LL LLS NTR RS
n = 761 n = 790 n = 1866 n = 768 n = 741 n = 712 n = 735 n = 762 n = 740 n = 579 n = 882 n = 628
Age 45 ± 13 58 ± 8 37 ± 14 68 ± 6 46 ± 13 59 ± 7 40 ± 15 68 ± 7 45 ± 13 59 ± 7 38 ± 15 69 ± 6
Sex (% male) 0.42 0.48 0.33 0.43 0.42 0.48 0.35 0.43 0.42 0.47 0.35 0.43
Smoking (% current) 0.15 0.11 0.19 0.10 0.15 0.12 0.19 0.10 0.15 0.13 0.18 0.09
BMI 25 ± 4 25 ± 4 24 ± 4 28 ± 4 25 ± 4 25 ± 3 25 ± 4 28 ± 4 25 ± 4 25 ± 3 25 ± 4 28 ± 4
Lymp (% of cells) 34 ± 8 29 ± 7 35 ± 9 36 ± 8 35 ± 7 29 ± 7 35 ± 9 36 ± 8 34 ± 8 29 ± 7 35 ± 9 36 ± 8
Mono (% of cells) 9 ± 2 5 ± 2 8 ± 3 7 ± 2 9 ± 2 6 ± 2 8 ± 3 7 ± 2 9 ± 2 6 ± 2 9 ± 3 7 ± 2
Gran (% of cells) 57 ± 8 63 ± 7 56 ± 9 57 ± 8 57 ± 8 63 ± 7 57 ± 9 57 ± 9 57 ± 8 63 ± 7 56 ± 9 57 ± 8
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analysis and replication were defined by Bonferroni cor-
rection (p < 0.05) for the number of CpGs/genes tested.
Below, we first describe the performance of the base
model for methylation and expression data. Then, we
describe, per category, how the various options affected
the number of replicated signals (as a measure of sensi-
tivity) and percentage of replicated signals (as a measure
of true-positive rate in the discovery) and the overlap of
significant CpGs/genes between analysis strategies. All
results are Bonferroni corrected.
Fig. 1 a Overview of DNA methylation analysis steps and commonly used options. We identified four steps in the procedure which often vary in
literature: (A) DNAm value preprocessing, (B) statistical test, (C) cell count correction, (D) hidden confounder correction. We selected one
combination of options and then varied these a single step at the time. These models were applied to age, BMI, and smoking. Each model was
meta-analyzed in each combination of three discovery and one replication cohorts. The average replication rate and number of replicated genes
of these four analyses were used to evaluate strategies. The base model is connected by the black line and includes Beta-3IQR dataset, an LM
model, measured cell count correction, known technical confounder correction (TCs) (plate and row) and applying Bonferroni correction. HCs,
hidden confounders, calculated after regressing out technical covariates (2), cell counts (3) or both (4). b Overview of gene expression analysis
steps and commonly used options. We identified four steps in the procedure which often vary in literature: (A) normalization, (B) expression, (C)
tests, and (D) technical covariates. We selected one combination of options and then varied these a single step at the time. These models were
applied to age, BMI, and smoking. Each model was meta-analyzed in each combination of three discovery and one replication cohorts. The
average replication rate and number of replicated genes of these four analyses were used to evaluate strategies. The base model is connected by
the black line; Voom normalization, including all genes, a LM for statistical analysis, including technical covariates and cell counts and applying
Bonferroni correction
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DNA methylation strategy performance
The base model included using normalized beta values
and removing outliers based on the three interquartile
range strategy (beta-3IQR), a linear model (LM), mea-
sured cell counts, and technical covariates, as described
in more detail in the methods. This resulted in an aver-
age of 30,275 significantly replicated CpGs for age (range
4621–59,087), 6 replicated CpGs for BMI (range 5–7),
and 217 replicated CpGs for smoking (range 168–279).
The corresponding replication rates were on average
40% for age (range 5–93%), 52% for BMI (range 23–
86%), and 31% for smoking (range 20–47%). All sum-
mary results are shown in Figs. 2a and 3a and Add-
itional file 1: Table S1a. Below, we describe per category
how different options influenced these results.
A) DNAm value preprocessing: For age, all
normalization methods showed similar replication
rates and slightly higher replication number
compared to the base model. The same was
observed for smoking, except that the RIN method
performed more similar to the base model than the
beta, M, or M-3IQR methods. The replicated num-
ber and rate of CpGs were largely the same across
methods. For BMI, given the small numbers of
CpGs (e.g., 6 for the base model), it was difficult to
robustly compare results.
B) Statistical tests: Compared to the base model, a
linear mixed model (LMM) reported a slightly
higher number of replicated hits for age and
smoking. The robust linear mixed model (RLMM)
reported lower numbers of replicated CpGs for age
and similar number of replicated CpGs for smoking.
Replication rates were nearly identical to the LM
base model for all exposures. The replicated CpGs
were shared across methods.
C) Cell count adjustment: Without correction for cell
counts, fewer replicated CpGs were found for age
(83% compared to the number of replicated CpGs
in the base model), but no differences were seen for
BMI and smoking (Fig. 2a). For age, adjusting for
Houseman imputed cell counts substantially
decreased the number of significantly replicated
CpGs; Houseman6 resulted in 18,368 CpGs for age
(61% of the base model), and Houseman3 resulted
in 10,678 CpGs for age (35% of the CPGs compared
to the base model). The replication rate with
Houseman6 was similar as compared to the base
model, but Houseman3 resulted in a slightly lower
replication rate as compared to the base model. For
smoking, using Houseman imputed cell counts
resulted in a slightly higher number of replicated
CpGs; Houseman6 resulted in 243 CpGs (112%
compared to the base model), while Houseman3
resulted in 259 CpGs (119% compared to the base
model). When examining the overlap between the
CpGs in the different cell count adjustment
strategies across all four cohorts (Fig. 3a) for
smoking, we observed that a total of 652 CpGs
were common for all cell count adjustment
methods. In addition, a relatively large number of
CpGs were only observed by Houseman6 and 3,
respectively (312 and 220 CpGs).
D) Correction for hidden confounders (HCs): HCs were
calculated in three additional models (model 1
being the base model); model 2, HCs
independent of the described covariates, but not
measured differential cell counts; model 3, HCs
independent of the described covariates, but not
known technical covariates; and model 4, using
HCs independent of the exposure of interest, age,
sex, known technical covariates, and measured
differential cell counts. For age, adjusting for five
HCs resulted in a decreased number of
significantly replicated CpGs: 7509 in model 4
(25% compared to the base model), 6054 in
model 3 (20% compared to the base model), and
3621 in model 2 (12% compared to the base
model). In contrast, for BMI and smoking, these
three HC models showed an increase in the
number of significantly replicated CpGs: 8, 9, and
10 for BMI and 297 (137% of the base model),
311 (143% of the base model), and 325 (150% of
the base model) for smoking in models 4, 3, and
2, respectively. Thus, for age, a large number of
CpGs were not detected when correcting for
HCs, while for smoking and BMI, a number of
CpGs were found only when using HC
correction. The replication rates were very
similar across all models.
RNA sequencing strategy performance
The base model (Voom normalization, no expression
inclusion threshold, LM, technical covariates, and
measured cell counts) resulted on average in 842 sig-
nificantly replicated genes for age (range 610–1082),
881 replicated genes for BMI (range 651–1029), and
354 replicated genes for smoking (range 268–409).
The corresponding mean replication rates were 54%
for age (range 28–80%), 55% for BMI (range 30–74%),
and 51% for smoking (range 30–69%). Below, we de-
scribe per category how different options influenced
these results, as available in Additional file 1: Table
S1b and shown in Figs. 2b and 3b.
A) Normalization method: The DESeq and edgeR
normalization methods reported a slightly lower
number of replicated genes with the same
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Fig. 2 (See legend on next page.)
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replication rate compared to the base model (93%
and 91% of the base model, respectively). The
normalization method did not influence which
genes were replicated. This pattern was observed
for all three exposures.
B) Gene expression inclusion criteria: Including low
(average CPM > 1 in 20% of samples) and higher
expressed genes (1. low) or medium (average
CPM > 1) and higher expressed genes (2. med)
provided slightly more replicated genes for age
(both 107% compared to the base model) at a
similar replication rate. The most stringent
threshold (3. hi) also resulted in a similar
replication number (98% compared to the base
model) and percentage (98% compared to the base
model). Mostly the same genes were replicated
regardless of the inclusion threshold.
C) Statistical tests: limma’s linear model fit (limma)
test resulted in slightly more replicated genes, at the
cost of a lower replication rate (lower specificity).
The glmQLF test from edgeR showed a lower
number of replicated genes. GLM showed nearly
the same results as the base model. These findings
were consistent across the exposures, with smaller
differences for BMI.
D) Covariates: For age, correcting solely for technical
covariates or cell counts resulted in a large increase
(119% compared to the base model) in replicated
genes. For BMI and smoking, the number of
replicated genes, as well as the replication rate,
decreased when removing these covariates.
Correcting for five principal components instead of
technical covariates or cell counts decreased the
number of replicated signals to 51%, 53%, and 46%
of the base model for age, BMI, and smoking,
respectively. Similarly, the replication rate decreased
to 87%, 96%, and 96% for age, BMI, and smoking
compared to the base model, respectively.
Conversely, five hidden confounders added to the
technical covariates and cell counts in the base
model increased the replication number to 100.4%,
114%, and 101.4% compared to the base model for
age, BMI, and smoking, and increased the
replication rate to 107%, 103%, and 103% of the
base model for age, BMI, and smoking, respectively.
In addition to finding fewer replicated genes after
PC correction, the identified genes were not the
same as the base model, and other methods did not
observe these genes. Similarly, when adding five
HCs, many genes identified in the model with HCs
were not observed in the other models, but the
difference was smaller than that for the model
including PCs.
FDR instead of Bonferroni correction
In addition to the comparisons described above, all ana-
lyses were also repeated using FDR correction in the dis-
covery analysis instead of Bonferroni correction. All
analyses using FDR showed a higher number of repli-
cated CpGs and genes, at the cost of a much smaller
replication rate. For example, for the base model for age,
30,275 CpGs and 842 genes were replicated at replica-
tion rates of 40% and 47%, respectively, when using Bon-
ferroni correction. When using FDR correction, the
number of CpGs increased by 18% and the replication
rate decreased by 18%. Similarly, the number of genes
increased by 98% and the replication rate decreased by
20%.
METAL or GWAMA for meta-analysis
As the GWAMA tool requires input that is not provided
by some RNA expression statistical methods, we opted
to use only METAL for the RNA-seq analysis. For those
(See figure on previous page.)
Fig. 2 a The number (x-axis) and percentage (y-axis) of replicated CpGs for age, BMI, and smoking (shown in columns). Per row, each step of the
analysis strategy is displayed. The yellow model is the reference model and remains the same in each column and row: Beta-3IQR dataset,
standard linear model (LM), measured cell count correction, and known technical confounders (bisulfite conversion plate and array row)
correction (TCs). The circles are average Bonferroni-corrected replication results. The bars indicate the range of the four leave-one-out analyses. In
each row, the other (non-yellow) colors represent alternative options: (A) Datatypes: beta without exclusion of outliers in green, M values in red,
M values with outlier exclusion using the 3IQR method in blue, and RIN in purple. (B) Statistical models: linear mixed models (LMM) in green and
robust linear mixed models (RLMM) in red. (C) Cell count adjustment: Houseman6 in green, Houseman3 in red, and none in blue (see the
“Methods” section for details). (D) Hidden confounder (HC) correction: model 1 in purple, model 2 in green, and model 3 in red (see the
“Methods” section for details). b The number (x-axis) and percentage (y-axis) of replicated genes for age, BMI, and smoking (shown in columns).
Per row, each step of the analysis strategy is displayed. The yellow model is the reference model and remains the same in each column and row:
Voom normalization, including all genes, standard linear model (LM), correcting for technical covariates (TC) and cell counts (CC). The circles are
average Bonferroni-corrected replication results. The bars indicate the range of the four leave-one-out analyses. In each row, the other (non-
yellow) colors represent alternative options: (A) Normalization methods: DESeq normalization in blue and edgeR in red. (B) Gene inclusion:
removing very low-expressed genes (blue), low-expressed genes (red), or medium-expressed genes (green). (C) Statistical models: A limma linear
model Fit in red (limma), a standard GLM in blue, and the edgeR GLM adaptation in green. (D) Covariates: correcting solely for technical
covariates (TC; blue) or cell counts (CC; red) or replacing both for the first five principal components (5PCs; green); the last option is by adding
five hidden confounders (HCs) to the technical covariates and cell counts (5HCs; purple)
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RNA-seq models where both could be run, the results
were identical.
Evaluation using different p value cutoffs
The results for additional p value cutoffs (FDR, uncor-
rected < 1 × 10–8 and uncorrected < 0.05) are available in
Additional file 1: Table S1 and Additional file 2: Figure
S1. Less stringent cutoffs led to an increase in absolute
numbers of replicated signals but at a decreased relative
replication rate for both DNAm and RNA-seq. Most
models responded similarly to this change, and the re-
spective performance between methods did not change.
For BMI and smoking in the DNAm analyses, the low-
est threshold p < 0.05 showed fewer replicated CpGs as
compared to the other three thresholds. This was caused
by a 333-fold increase of significant CpGs in discov-
ery meta-analysis for BMI and an 8.6-fold increase for
smoking when we used the lowest threshold in com-
parison to the FDR threshold. In contrast, the discov-
ery meta-analysis showed only a 1.12-fold increase of
significant CpGs for age. As a result, the Bonferroni
threshold for replication was strongly increased, and
most of the previously replicated CpGs did not sur-
vive this threshold.
Fig. 3 a CpG overlaps. The three 4-way Venn diagrams on top
indicate the overlap in CpGs for each of the individual cohorts.
These are based on the base model, using Bonferroni correction.
The four diagrams below indicate the overlap between the
strategies for each step, shown here for age, BMI, and smoking.
These are the same strategies as shown in Fig. 2a. Yellow always
represents the base model, and the green, red, blue, and purple
colors belong to alternative strategies. (A) Beta values dataset in
green, M-3IQR in blue, M in red, and RIN in purple. (B) LMM in green
and RLMM in red. (C) Houseman6 imputed cell counts in green,
Houseman3 imputed cell counts in red, and no cell count correction
in blue. (D) Hidden confounder (HC) correction: model 1 (HCs
independent of the exposure of interest, age, sex, known technical
covariates, but not measured differential cell counts) in purple,
model 2 (HCs independent of the exposure of interest, age, sex,
measured differential cell counts, but not known technical
covariates) in green, and model 3 (independent of the exposure of
interest, age, sex, known technical covariates, and measured
differential cell counts) in red. b Gene overlaps. The three 4-way
Venn diagrams on top indicate the overlap in genes for each of the
individual cohorts. These are based on the base model, using
Bonferroni correction. The four diagrams below indicate the overlap
between the strategies for each step, shown here for age, BMI, and
smoking. These are the same strategies as shown in Fig. 2b. Yellow
always represents the base model, and the blue, green, and red
colors belong to alternative strategies. (A) DESeq normalization in
blue and edgeR in red. (B) Removing very low-expressed genes
(blue), low-expressed genes (red), or medium-expressed genes
(green). (C) A limma linear model Fit in red, a standard GLM in blue,
and the edgeR GLM adaptation in green. (D) Correcting for only
technical covariates (blue) and only cell counts (red), adding five
hidden confounders (purple), or replacing both for the first five
principal components (green)
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For the normalization options (A) and covariate cor-
rection options (D) in RNA-seq analyses, the respective
differences between the options were unchanged de-
pending on the p value cutoff. For the gene inclusion
thresholds (B), it showed that including only the most
highly expressed genes yields a slightly higher replication
rate using the uncorrected p value threshold. For the
statistical test comparison (C), using lower p value
thresholds (FDR and uncorrected) provided a more pro-
nounced difference between the models.
Categorical analyses for age and BMI
For DNAm and RNA-seq, when we used age/BMI as
categorical instead of continuous exposures, the differ-
ences between methods remained largely the same.
However, the categorical models consistently resulted in
a lower number and percentage of significantly repli-
cated CpGs/genes as compared to the continuous
models. The only exception was in the hidden con-
founder (HC) correction model for age, where the cat-
egorical models resulted in a larger number of
significantly replicated CpGs/genes as compared to the
continuous models. The results for these categorical
models can be found in Additional file 1: Table S1 and
Additional file 3: Figure S2.
Discussion
We evaluated commonly used analysis strategies for
population-based datasets for DNA methylation and
RNA sequencing in almost 3000 participants from four
Dutch cohorts. For each step in the analysis procedure,
we compared commonly used options and reported their
influence on the exposure of interest. These results will
aid in comparing studies with different analysis strategies
and can help in the choice between alternative analysis
strategies.
The four included cohorts differed on some important
parameters (e.g., age). As a combined dataset would not
have easily been able to distinguish true age effects from
batch effects between age-differing cohorts, we decided
to run cohort-level analyses first and then meta-analyze
the datasets, as is commonly done in meta-analyses of
“omics” data [35]. As these exposure differences will also
result in different power between cohorts for each ex-
posure, we meta-analyzed each combination of three co-
horts and replicated in the fourth [36]. Therefore, when
a cohort of low power for an exposure performs poorly
as replication cohort, while a powerful cohort for that
exposure replicated many signals, these effects were av-
eraged out and provided a reasonable aggregated per-
formance of each strategy [37].
For DNA methylation data, our evaluation leads to the
following considerations/recommendations:
DNAm value preprocessing: There were no large differ-
ences between the different methylation values. We sug-
gest to use beta-3IQR in order to avoid spurious
findings based on DNA methylation outliers, but we do
not expect another option to have a large influence on
the results.
Statistical tests: The theoretical advantage of using an
RLMM over LM or LMM is considered to be that it is
less sensitive to exposure and methylation outliers and
heteroscedasticity. However, LM, LMM, and RLMM
provided nearly identical results, and the analysis run-
ning time for RLMM is considerably longer. Therefore,
LM or LMM approaches might be preferred as they are
simple and widely used base-R functions.
Cell count adjustment: Beforehand, we expected that
differential cell counts are a major influence on DNA
methylation data measured from whole blood [38]. In-
deed, we observed a large influence of cell counts on
age, but not on BMI or smoking. These results were in
line with previous work which also found that adjusting
or not adjusting for blood cell counts had no substantial
impact on EWASs of BMI and smoking [39]. For all ex-
posures, we observed influence of Houseman6/3 cell
counts on the analysis, with a larger deviation from the
measured cell counts (base model) for Houseman3 than
Houseman6. Therefore, we recommend the adjustment
for measured cell counts if available. If not, the House-
man6 estimated six cell counts could be used for expo-
sures other than age.
Correction for HCs: Adjusting for five HCs substan-
tially influenced the results. For age, adjusting for five
HCs substantially decreased the number of replicated
CpGs. For BMI and smoking, adjusting for five HCs
seemed to improve the results by improving the number
of replicated CpGs. Therefore, for exposures other than
age, adjusting for HCs is highly recommended in order
to remove unknown variation from the data.
For RNA expression data, our evaluation leads to the
following considerations/recommendations:
Normalization method: There was no large influence
of normalization methods. The Voom method resulted
in slightly more replicated genes and is recommended.
Gene expression inclusion threshold: The gene inclu-
sion threshold displayed minimal influence on the re-
sults. To be complete, it is suggested to include and
report all genes in the dataset.
Statistical method: In our datasets, the standard LM/
GLM models performed similarly to the custom limma/
edgeR methods. However, it is possible that datasets of
smaller sample sizes (e.g., fewer than 20 samples) benefit
more from the custom methods. For larger datasets, the
standard, widely used LM and GLM are easier to use
and could provide easier compatibility with other appli-
cations (e.g., meta-analysis).
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Covariates: In our results, correcting for PCs did not
improve performance and is not recommended when
technical covariates and/or cell counts are available. In
our datasets, the PCs correlated to the technical covari-
ates, to the cell counts, and in some occasions to the ex-
posures (mostly age); this likely led to overcorrection
when PCs where added on top of these covariates. Cor-
recting for five hidden confounders on top of the base
model improved the results for all exposures and is rec-
ommended to use. When doing so, care should be taken
that the hidden confounders are not correlated to the
exposure of interest (or a confounder which is correlated
to the exposure) which could remove true results. At
current, adjusting for confounders using HCs is not the
standard practice in RNA-seq analysis, but should be im-
plemented more widely based on these findings. Add-
itionally, we did not use the Bacon package to correct
for inflation of test statistics, as this is not yet widely
used for RNA-seq data. However, applying bacon correc-
tion on RNA-seq data is becoming more common and
should be considered in future RNA-seq studies [28].
Evaluation using different p value cutoffs
For all models, we observed a balance with more strin-
gent p value cutoffs resulting in fewer replicated signals,
but a larger replication rate. In general, we recommend
using Bonferroni-corrected p values with a cutoff of p <
0.05. The FDR-corrected p values can provide an alter-
native. Decreasing the p value threshold stringency al-
ways leads to increased false positives and thus a lower
replication rate. Using uncorrected p value cutoffs
(whether nominal 0.05 or a too conservative 1E−8) is
not recommended.
For DNAm, the differences between methods were
similar for all thresholds, and the main conclusions did
not change. For RNA-seq, these results further show
that the GLM and edgeR’s glmQLF models are more
conservative (lower number but higher percentage of
replicated signals) while limma’s linear model fit is more
liberal (higher number but lower percentage of repli-
cated signals) compared to the base model. The LM
model is still recommended.
Categorical analyses for age and BMI
To assess whether strategies are influenced by the con-
tinuous or categorical definition of the exposure, we an-
alyzed age and BMI both as continuous and categorical
(i.e., highest versus lowest tertiles) exposures of interest.
All models responded similarly to the categorical expos-
ure in comparison to the continuous exposure, showing
lower number and percentage of replicated signals, indi-
cating lower power for categorical exposures. For both
DNAm and RNA-seq analyses, we observed differences
in performance between models only with HC
correction. The models with five HCs for age performed
worse when we used age as a categorical variable with
the highest vs lowest tertiles and excluded the middle
tertile. Likely, these results indicate that HCs are insuffi-
ciently adjusted for age when it is included as a categor-
ical variable (compared to continuous). Overall, these
results seem robust for categorical/continuous exposure
definitions, but do emphasize that HC correction may
be challenging when working with categorical exposures.
For continuous variables and most categorical variables
(e.g., BMI tertiles and smoking), using HCs performed
best and is still recommended.
Although most of the differences we observed between
strategies were consistent across exposures and cohorts,
these results might not be applicable to all other DNAm
array or RNA-seq studies. For example, we have studied
three exposures for which we could observe relatively
large differences in blood methylation or expression,
with the exception of BMI in methylation. We observed
differences in performance between exposures, for ex-
ample, when correcting for different cell counts, HCs or
PCs in age, or the low number of replicated CpGs for
BMI. As such, a universally optimal model could not be
defined and performance of these different strategies
needs to be confirmed for other exposures. However,
performance differences between many strategies were
consistent across exposures (specifically BMI and smok-
ing), individual cohorts and DNAm/RNA-seq datasets,
and will likely hold even in other exposures or datasets.
In this study, we have compared multiple analysis
strategies on four cohorts and suggested a base model to
reduce heterogeneity between studies. The most ideal
validation would be to re-analyze a number of published
studies using this optimal model and demonstrate a de-
crease in heterogeneity between results of previous ana-
lyses and those with the new model. However, to our
knowledge, for none of the studies we investigated this
was possible, due to lack of publically available pheno-
typic information or lack of publically available
individual-level DNAm/RNA-seq data. As it may not al-
ways be possible to share such data publicly, this further
shows the need for more standardized DNAm/RNA-seq
methods, so results between studies can be compared
more easily.
Similarly, we studied four relatively large population-
based studies. Results obtained from smaller studies, or
other types of populations, for example, patients or sam-
ples of extreme exposures, might yield different results
and require alternative strategies. These comparisons
were beyond the scope of our study, which focused on
commonly used strategies. Our results might be most
generalizable to population-based DNAm and RNA-seq
studies. Finally, our study lacked a gold standard, which
will have limited our ability to distinguish strategies with
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many false positives from strategies with a high sensitiv-
ity. Despite these factors, we evaluated the consistent in-
fluences of analysis strategies and options and reported
analysis suggestions for both datatypes. We hope that
these results will aid other researchers in selecting an
appropriate analysis strategy and/or in evaluating the
impact, a certain strategy might have had on the ob-
served results.
Conclusions
Based on our findings, for DNA methylation studies, we
recommend to correct for measured cell counts when
available and include additional hidden confounders (in-
dependent of cell counts and technical covariates) in the
statistical model. We suggest using Beta-3IQR values
and the LM statistical test for DNAm studies, although
alternatives will yield similar results and can also be
used. For RNA sequencing studies, we recommend using
hidden confounders in addition to technical covariates
and measured cell counts. The use of principal compo-
nents is not recommended. We recommend using the
Voom normalization method and suggest to include all
genes in the analysis (independent of expression level).
Finally, we suggest using a LM or GLM statistical model
for large studies and a custom method like limma/edgeR
for smaller studies. Our results show a large difference
in replication results between cohorts, and therefore,
using replication in DNAm or RNA-seq analysis is also
recommended.
Methods
Data generation
Generation of the BIOS gene expression dataset was de-
scribed previously [33, 34]. In short, DNA and RNA
were collected from 3296 unrelated participants of six
Dutch populations as described below. Analyses were re-
stricted to four large cohorts; LifeLines (LL), Leiden
Longevity Study (LLS), Netherlands Twin Register
(NTR), and Rotterdam Study (RS). We included 2950
participants with DNAm array data and 2829 partici-
pants with RNA-seq data. Characteristics for these co-
horts are described in Table 1.
DNA methylation data
Whole blood was used to isolate genomic DNA. Five
hundred nanograms of genomic DNA was bisulfite con-
verted using the EZ DNA Methylation kit (Zymo Re-
search, Irvine, CA, USA). Methylation profiling was then
performed using Infinium Illumina HumanMethylation
450k arrays according to the manufacturer’s protocol.
Quality control of the samples was performed using
MethylAid [40]. Probes with either a high detection p
value (> 0.01), low bead count (< 3 beads), or low success
rate (missing in > 5% of the samples) were set to missing.
Samples were excluded from the analysis if they con-
tained an excess of missing probes (> 5%). Imputation
was performed per cohort, subsequently, to impute the
missing values [41]. The raw beta values were normal-
ized using functional normalization [22] as implemented
in the minfi package [42]. The normalized beta values
were log2 transformed to produce M values [42].
RNA-seq data
Total RNA was derived from the whole blood, depleted
of globin transcripts using Ambion GLOBINclear, and
subsequently processed using the Illumina TruSeq v2 li-
brary preparation kit. On average, 40 million paired-end
reads of 50 bp were generated per participant using illu-
mina’s Hiseq 2000. Samples were demultiplexed using
CASAVA and aligned to the hg19 reference genome
using STAR [43]. Alignments were sorted, read groups
were added using picard [44], and gene expression was
quantified using featureCounts [45]. We selected partici-
pants for which all covariates were available (sex, age,
BMI, smoking status, and measured cell counts). Raw
count matrices per cohort were used for analysis.
Base model and analysis
The main steps in epigenomic and transcriptomic ana-
lyses often vary between studies, as shown in Fig. 1a and
b, respectively. First, we compiled a base model with a
single option from each step in Fig. 1a and b. These op-
tions were then replaced, one at a time, in the various
analysis strategies. These strategies were applied to three
exposures of interest (age, BMI, and smoking status) in
each cohort (LL, LLS, NTR, and RS). Every combination
of three discovery cohorts was meta-analyzed and repli-
cated in the remaining cohort (leave-one-out method).
The average number and percentage of replicated CpGs/
genes were calculated from these four results and were
used to evaluate the performance of each strategy. Age,
sex, measured percentages of WBC counts (granulocytes,
lymphocytes, and monocytes), and technical covariates
specified below were included as covariates unless speci-
fied otherwise. Replication analyses were always Bonfer-
roni corrected. Meta-analyses were performed using
GWAMA (DNAm array data) [46] or METAL (RNA-seq
data) [47].
DNA methylation array-specific analysis strategies
The technical covariates used for each DNAm array ana-
lysis were bisulfite conversion plate and array row. All
analyses were corrected for inflation and bias using the
Bacon package [28], which estimates empirical null dis-
tribution using the Bayesian method. The following steps
were investigated in detail (see Fig. 1a).
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A) Methylation values: We investigated five types of
DNAm values, namely (1) beta values, representing
the percentage of methylation between 0
(unmethylated) and 1 (methylated) [25]; (2) beta-
3IQR values, where beta values of outlier samples
per methylation CpG were removed (replaced with
NAs) using the three interquartile range (IQR)
strategy, i.e., any beta value below quartile (Q)1 −
3×IQR or above Q3 + 3×IQR was removed [48]; (3)
M values, calculated as the log2 ratio of the methyl-
ated probe intensity and unmethylated probe inten-
sity [49]; (4) M-3IQR values, where M values of
outlier samples per methylation CpG were removed
using the 3xIQR strategy as described above [48];
and (5) RIN (rank-based inverse normal transform-
ation) values, wherein beta values for each sample
were ranked and replaced with the corresponding
standard normal quantiles in order to create a nor-
mal distribution [50]. We selected beta-3IQR values
for the base model.
B) Statistical tests: We investigated three types of
linear models: (1) linear regression model (LM), (2)
linear regression mixed model (LMM), and (3)
robust linear regression mixed model (RLMM). We
selected LM for the base model.
C) Cell count correction: (1) For the base model, we
used the percentages of differential measured cell
counts of granulocytes, lymphocytes, and
monocytes. This base model was compared with
three other models: (2) a model without cell count
correction, (3) a model adjusted for the cell
subtypes imputed with the reference-based House-
man method [26], using the default percentage
counts of all six imputed cell types: granulocytes,
monocytes, NK cells, B cells, CD4+, and CD8+ T
lymphocytes. We refer to this as “Houseman6”, (4)
a model adjusted for the same imputed cell counts,
but using three instead of six cell types: granulo-
cytes, monocytes, and lymphocytes (sum of NK
cells, B cells, CD4+, and CD8+ T lymphocytes) in
order to match with measured cell counts of the
base model. We refer to this as “Houseman3.”
D) Hidden confounder (HC) correction; (1) For the
base model, we used known technical confounder
correction (bisulfite conversion plate and array
row). This base model was compared with three
more models that were corrected for HCs
calculated from the CATE package [27, 28]. These
were calculated per cohort per exposure. (2) We
calculated five HCs independent of the exposure of
interest (BMI or smoking), age, sex, and known
technical covariates. However, we did not regress
out measured differential cell counts, and therefore,
we assume that the HCs reflect cell counts. This
model contained age, sex, technical confounders,
and five HCs as covariates. (3) HCs were calculated
by regressing out the exposure of interest, age, sex,
and also measured differential cell counts. In this
case, we did not regress out known technical
confounders, and therefore, these HCs are thought
to reflect technical confounders. This model
contained age, sex, measured differential cell counts
and 5 HCs as covariates. (4) HCs were calculated by
regressing out not only the exposure of interest,
age, and sex, but also the measured differential cell
counts and known technical covariates. In this case,
HCs can be regarded as any more potential hidden
biological or technical confounders that might
influence the data in addition to the differential cell
counts and technical confounders’ correction. This
model contained age, sex, measured differential cell
counts, known technical confounders, and five HCs
as covariates.
RNA sequencing-specific analysis strategies
All RNA-seq strategies were corrected for technical co-
variates: sequencing batch (flow cell) and average GC
percentage in the reads, in addition to the biological co-
variates mentioned before. We compared the following
steps in detail (see also Fig. 1b).
A) Normalization method: Three commonly used
RNA-seq normalization methods: (1) Voom, (2)
edgeR, and (3) DESeq, were investigated. The edgeR
and DESeq methods adopted a Trimmed mean of
M value normalization (TMM) [51, 52]. Voom
adopted edgeR’s normalization but first raised zeros
to a minimum value of 1 and performed a log trans-
formation [53]. We selected Voom for the base
model.
B) Expression inclusion criteria: We varied the genes
allotted to normalization using four common
inclusion CPM (counts per million) thresholds of
gene expression. (1) All genes expressed at any level
in at least one sample were included. (2) All genes
with a CPM ≥ 1 in ≥ 20% of the samples were
included. (3) Genes with an average CPM ≥ 1
across all samples were included. (4) All genes
with an average CPM ≥ 10 across all samples
were included. In the base model, all genes were
included (option 1).
C) Statistical tests: We used four commonly used
statistical tests: (1) a default linear model (LM) [54];
(2) a default generalized linear model (GLM) with
negative binomial distribution; (3) the linear model
fitfunction of the limma package, which was a
weighted linear model where genes with a large
variance (e.g., genes with very low expression) had
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lower weights; (4) the edgeR’s generalized linear
model fit (glmQLF), which used a negative binomial
distribution followed by a log ratio likelihood (LR)
test. Options 3 and 4 were RNA-seq-specific hier-
archical models that take into account differences
in variance estimates across genes [51, 53]. Option
1 was included in the base model. Option 4 was also
run on the Voom normalized dataset. Option 2 and
3 were run on the edgeR normalized dataset as the
negative binomial distribution did not apply after
Voom’s log transformation.
D) Technical correction: We used five commonly used
approaches to correct for technical factors. (1) We
included technical covariates (GC percentage and
flow cell) and measured cell counts. (2) Corrected
only for technical covariates. (3) Corrected only for
cell counts. (4) Replaced technical covariates and
cell counts by the first five principal component
PCs, calculated per cohort using the prcomp
function in R. (5) Added five hidden confounders
to the technical covariates and cell counts.
Hidden confounders were calculated per cohort
per exposure and were adjusted for the
respective exposure, age, sex, technical covariates,
and cell counts.
Evaluating strategy performance
In each analysis, three of the four cohorts were meta-
analyzed in the discovery and the fourth cohort was used
for replication. We repeated for each combination of
three discovery and one replication cohort. The number
of significantly replicated CpGs/genes was obtained for
each repetition, as well as the percentage of CpGs/genes
from discovery that reached replication (replication rate).
For both the number and percentage of replicated sig-
nals, the average of the four combinations was calculated
and used to evaluate performance of each strategy. We
compared each strategy to the base model and looked
for consistent differences in replication number or per-
centage across exposures.
Categorical analyses for age and BMI
In order to investigate whether an optimal analysis strat-
egy is dependent on whether the independent variable is
continuous or categorical, we expanded our association
analyses on age and BMI by converting them into ter-
tiles. We used the highest and lowest tertiles to define
the categories. The results of these categorical analyses
were compared with the results of the continuous ana-
lyses where age and BMI were used as continuous mea-
sures. For DNAm, we did not analyze BMI into
categorical exposure because the numbers of signifi-
cantly replicated CpGs were already small for the con-
tinuous models (average of < 12 CpGs) when a
Bonferroni threshold was used for multiple testing. This
made it difficult to draw conclusions when comparing
different methods within continuous models and there-
fore would have made it even more difficult to compare
results between categorical models.
Evaluation using different p value cutoffs
For all the comparisons mentioned, both discovery and
replication results were Bonferroni corrected. In addition
to using the Bonferroni threshold for the discovery re-
sults, we applied three other thresholds to evaluate the
robustness of the approaches: (1) Benjamini-Hochberg
FDR threshold (FDR p value < 0.05), (2) highest
threshold (uncorrected p value threshold < 1 × 10–8),
and (3) lowest threshold (uncorrected p value thresh-
old < 0.05). Differences between models were com-
pared between p value thresholds to establish that the
models show similar (respective) results independent
of p value thresholds.
In addition, for each strategy, we performed a meta-
analysis of all four cohorts for DNA methylation and
RNA expression. Overlaps in CpGs/genes between all
strategies per step were determined using Venn dia-
grams to ascertain if the same CpGs/genes were identi-
fied between strategies [55].
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13059-019-1878-x.
Additional file 1: Table S1. Results of all DNAm (A) and RNA-seq (B)
models.
Additional file 2: Figure S1. Results of the alternative multiple testing
corrections methods for the DNAm (A) and RNA-seq models (B).
Additional file 3: Figure S3. Results of the Age and BMI categorical
analysis for DNAm (A) and RNA-seq (B) models.
Additional file 4. Review history. Comments of the reviewers and
authors’ responses.
Peer review
Yixin Yao was the primary editor of this article and managed its editorial
process and peer review in collaboration with the rest of the editorial team.
Review history
The review history is available as Additional file 4.
Authors’ contributions
Authors JvR and PM performed all analyses and wrote the manuscript. The
BIOS datasets were generated and QC’ed. by the BIOS Consortium, as is
described in detail here: http://www.bbmri.nl/acquisition-use-analyze/bios/,
including details on contributions of all consortium members. JvR, PM, AC,
JF, JvD, RJ, LF, PH, BH, and JvM contributed to the analysis and interpretation
through regular calls and revisions of the manuscript. All authors read and
approved the final manuscript.
Funding
This work was partially funded by the BBMRI-NL, a research infrastructure fi-
nanced by the Netherlands Organization for Scientific Research (NWO project
184.021.007).
Rooij et al. Genome Biology          (2019) 20:235 Page 12 of 14
Availability of data and materials
The datasets from BIOS are available from the European Genome-Phenome
Archive by accession number EGAS00001001077 (https://www.ebi.ac.uk/ega/
studies/EGAS00001001077). Alternative options to access the data are avail-
able through the BIOS website; https://www.bbmri.nl/acquisition-use-
analyze/bios/ [34].
Ethics approval and consent to participate
Each biobank received ethical approval for their population study. No
additional approval was required.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the
Netherlands. 2Maastricht Centre for Systems Biology (MaCSBio), Maastricht
University, Maastricht, the Netherlands. 3Faculty of Medical Sciences,
University of Groningen, Groningen, the Netherlands. 4The Generation R
Study Group, Department of Epidemiology, Erasmus Medical Center,
Rotterdam, the Netherlands. 5The Generation R Study Group, Department of
Pediatrics, Erasmus Medical Center, Rotterdam, the Netherlands. 6Department
of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the
Netherlands. 7Department of Psychiatry, VU University Medical Center,
Amsterdam, the Netherlands. 8Department of Genetics, University of
Groningen, Groningen, the Netherlands. 9Department of Human Genetics,
Leiden University Medical Center, Leiden, the Netherlands. 10Centre for
Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life
Sciences, Radboud University Medical Center Nijmegen, Nijmegen, the
Netherlands. 11Molecular Epidemiology, Department of Biomedical Data
Sciences, Leiden University Medical Center, Leiden, the Netherlands.
Received: 31 March 2019 Accepted: 2 November 2019
References
1. Heyn H, et al. Distinct DNA methylomes of newborns and centenarians.
Proc Natl Acad Sci U S A. 2012;109(26):10522–7.
2. Lokk K, et al. DNA methylome profiling of human tissues identifies global
and tissue-specific methylation patterns. Genome Biol. 2014;15(4):r54.
3. Consortium GT, et al. Genetic effects on gene expression across human
tissues. Nature. 2017;550(7675):204–13.
4. Peters MJ, et al. The transcriptional landscape of age in human peripheral
blood. Nat Commun. 2015;6:8570.
5. Joehanes R, et al. Epigenetic signatures of cigarette smoking. Circ
Cardiovasc Genet. 2016;9(5):436–47.
6. Breitling LP, et al. Tobacco-smoking-related differential DNA methylation:
27K discovery and replication. Am J Hum Genet. 2011;88(4):450–7.
7. Breitling LP, et al. Smoking, F2RL3 methylation, and prognosis in stable
coronary heart disease. Eur Heart J. 2012;33(22):2841–8.
8. Wan ES, et al. Smoking-associated site-specific differential methylation in
Buccal mucosa in the COPDGene study. Am J Respir Cell Mol Biol. 2015;
53(2):246–54.
9. Zeilinger S, et al. Tobacco smoking leads to extensive genome-wide
changes in DNA methylation. PLoS One. 2013;8(5):e63812.
10. Shenker NS, et al. DNA methylation as a long-term biomarker of exposure
to tobacco smoke. Epidemiology. 2013;24(5):712–6.
11. Shenker NS, et al. Epigenome-wide association study in the European
Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies
novel genetic loci associated with smoking. Hum Mol Genet. 2013;22(5):
843–51.
12. Guida F, et al. Dynamics of smoking-induced genome-wide methylation
changes with time since smoking cessation. Hum Mol Genet. 2015;24(8):
2349–59.
13. Qiu W, et al. The impact of genetic variation and cigarette smoke on DNA
methylation in current and former smokers from the COPDGene study.
Epigenetics. 2015;10(11):1064–73.
14. Gao X, et al. DNA methylation changes of whole blood cells in response to
active smoking exposure in adults: a systematic review of DNA methylation
studies. Clin Epigenetics. 2015;7:113.
15. Wan ES, et al. Cigarette smoking behaviors and time since quitting are
associated with differential DNA methylation across the human genome.
Hum Mol Genet. 2012;21(13):3073–82.
16. Huan T, et al. A whole-blood transcriptome meta-analysis identifies gene
expression signatures of cigarette smoking. Hum Mol Genet. 2016;25(21):
4611–23.
17. Vink JM, et al. Differential gene expression patterns between smokers and
non-smokers: cause or consequence? Addict Biol. 2017;22(2):550–60.
18. Beineke P, et al. A whole blood gene expression-based signature for
smoking status. BMC Med Genet. 2012;5:58.
19. Verdugo RA, et al. Graphical modeling of gene expression in monocytes
suggests molecular mechanisms explaining increased atherosclerosis in
smokers. PLoS One. 2013;8(1):e50888.
20. Wu MC, et al. A systematic assessment of normalization approaches for the
Infinium 450K methylation platform. Epigenetics. 2014;9(2):318–29.
21. Wang T, et al. A systematic study of normalization methods for Infinium
450K methylation data using whole-genome bisulfite sequencing data.
Epigenetics. 2015;10(7):662–9.
22. Fortin JP, et al. Functional normalization of 450k methylation array data
improves replication in large cancer studies. Genome Biol. 2014;15(12):503.
23. Pidsley R, et al. A data-driven approach to preprocessing Illumina 450K
methylation array data. BMC Genomics. 2013;14:293.
24. Marabita F, et al. An evaluation of analysis pipelines for DNA methylation
profiling using the Illumina HumanMethylation450 BeadChip platform.
Epigenetics. 2013;8(3):333–46.
25. Du P, et al. Comparison of Beta-value and M-value methods for quantifying
methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587.
26. Houseman EA, et al. DNA methylation arrays as surrogate measures of cell
mixture distribution. BMC Bioinformatics. 2012;13:86.
27. Wang, J., et al., Confounder adjustment in multiple hypothesis testing. arXiv:
1508.04178, 2015.
28. van Iterson M, et al. Controlling bias and inflation in epigenome- and
transcriptome-wide association studies using the empirical null distribution.
Genome Biol. 2017;18(1):19.
29. Li P, et al. Comparing the normalization methods for the differential analysis
of Illumina high-throughput RNA-Seq data. BMC Bioinformatics. 2015;16:347.
30. Zhao S, Zhang B. A comprehensive evaluation of ensembl, RefSeq, and
UCSC annotations in the context of RNA-seq read mapping and gene
quantification. BMC Genomics. 2015;16:97.
31. Bullard JH, et al. Evaluation of statistical methods for normalization and
differential expression in mRNA-Seq experiments. BMC Bioinformatics. 2010;
11:94.
32. Robles JA, et al. Efficient experimental design and analysis strategies for the
detection of differential expression using RNA-sequencing. BMC Genomics.
2012;13:484.
33. Zhernakova DV, et al. Identification of context-dependent expression
quantitative trait loci in whole blood. Nat Genet. 2017;49(1):139–45.
34. Bonder MJ, et al. Disease variants alter transcription factor levels and
methylation of their binding sites. Nat Genet. 2017;49(1):131–8.
35. Copetti M, et al. Advances in meta-analysis: examples from internal
medicine to neurology. Neuroepidemiology. 2014;42(1):59–67.
36. George NI, et al. An iterative leave-one-out approach to outlier detection in
RNA-seq data. PLoS One. 2015;10(6):e0125224.
37. Evangelou E, Ioannidis JP. Meta-analysis methods for genome-wide
association studies and beyond. Nat Rev Genet. 2013;14(6):379–89.
38. Reinius LE, et al. Differential DNA methylation in purified human blood cells:
implications for cell lineage and studies on disease susceptibility. PLoS One.
2012;7(7):e41361.
39. Heiss JA, Brenner H. Impact of confounding by leukocyte composition on
associations of leukocyte DNA methylation with common risk factors.
Epigenomics. 2017;9(5):659–68.
40. van Iterson M, et al. MethylAid: visual and interactive quality control of large
Illumina 450k datasets. Bioinformatics. 2014;30(23):3435–7.
41. Hastie T, Tibshirani R, Narasimhan B., Chu G., Impute: impute: imputation for
microarray data. R package version 1.56.0. 2018.
42. Aryee MJ, et al. Minfi: a flexible and comprehensive Bioconductor package
for the analysis of Infinium DNA methylation microarrays. Bioinformatics.
2014;30(10):1363–9.
43. Dobin A, Gingeras TR. Optimizing RNA-Seq Mapping with STAR. Methods
Mol Biol. 2016;1415:245–62.
44. Picard, Picard toolkit. 2018.
Rooij et al. Genome Biology          (2019) 20:235 Page 13 of 14
45. Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose
program for assigning sequence reads to genomic features. Bioinformatics.
2014;30(7):923–30.
46. Magi R, Morris AP. GWAMA: software for genome-wide association meta-
analysis. BMC Bioinformatics. 2010;11:288.
47. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of
genomewide association scans. Bioinformatics. 2010;26(17):2190–1.
48. Upton G, Cook I. Understanding statistics; 1997.
49. Wood AR, et al. Defining the role of common variation in the genomic and
biological architecture of adult human height. Nat Genet. 2014;46(11):1173–
86.
50. Beasley TM, Erickson S, Allison DB. Rank-based inverse normal
transformations are increasingly used, but are they merited? Behav Genet.
2009;39(5):580–95.
51. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for
differential expression analysis of digital gene expression data.
Bioinformatics. 2010;26(1):139–40.
52. Anders S, Huber W. Differential expression analysis for sequence count data.
Genome Biol. 2010;11(10):R106.
53. Law CW, et al. voom: precision weights unlock linear model analysis tools
for RNA-seq read counts. Genome Biol. 2014;15(2):R29.
54. Core Team, R. R: a language and environment for statistical computing.
Vienna: R Core Team; 2015. p. 2015.
55. Heberle H, et al. InteractiVenn: a web-based tool for the analysis of sets
through Venn diagrams. BMC Bioinformatics. 2015;16:169.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Rooij et al. Genome Biology          (2019) 20:235 Page 14 of 14
